The activity and mRNA expression of β-secretase, cathepsin D, and cathepsin B in the brain of senescence-accelerated mouse

Journal of Alzheimer's Disease

Volumn 28, Issue 2, 2012, Pages 471-480

  Zhou, Jin Wu ^a   Cheng, Xiao Rui ^a   Cheng, Jun Ping ^a   Zhou, Wen Xia ^a   Zhang, Yong Xiang ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

cerebral cortex; hippocampus; senescence accelerated mouse; secretase

Indexed keywords

BETA SECRETASE; CATHEPSIN B; CATHEPSIN D; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE;

EID: 84863027994     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111469     Document Type: Article

References (62)

1. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid ß-peptide. Nat Rev Mol Cell Biol 8, 101-112. (Pubitemid 46432529)
2. Hook V, Schechter I, Demuth HU, Hook G (2008) Alternative pathways for production of beta-amyloid peptides of Alzheimer's disease. Biol Chem 389, 993-1006.
3. Cole SL, Vassar R (2007) The Alzheimer's disease ß-secretase enzyme, BACE1. Mol Neurodegener 2, 22.
4. Fleck D, Garratt AN, Haass C, Willem M (2011) BACE1 dependent neuregulin proteolysis. Curr Alzheimer Res, in press.
5. Takeda T, Hosokawa M, Takeshita S, Rino M, Higuchi K, Matsushita T, Tomita Y, Yasuhira K, Hamamoto H, Sh1mizu K, 1shii M, Yamamuro T (1981) A new murine model of accelerated senescence. Mech Ageing Dev 17, 183-194. (Pubitemid 12204873)
6. Morley JE (2002) The SAMP8 mouse: A model of Alzheimer disease? Biogerontology 3, 57-60. (Pubitemid 34284978)
7. Morley JE, Banks WA, Kumar VB, Farr SA (2004) The SAMP8 mouse as a model for Alzheimer disease: Studies from Saint Louis University. Int Congr Ser 1260, 23-28.
8. Butterfield DA, Poon HF (2005) The senescence-accelerated prone mouse (SAMP8): A model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp Gerontol 40, 774-783. (Pubitemid 41416540)
9. Pall'as M, Camins A, Smith MA, Perry G, Lee H, Casadesus G (2008) From aging to Alzheimer's disease: Unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 15, 615-624.
10. Del Valle J, Duran-Vilaregut J, Manich G, Casadesús G, Smith MA, Camins A, Pallàs M, PelegríC, Vilaplana J (2010) Early amyloid accumulation in the hippocampus of SAMP8 mice. J Alzheimers Dis 19, 1303-1315.
11. Manich G, Mercader C, Valle JD, Duran-Vilaregut J, Camins A, Pallàs M, Vilaplana J, Pelegrí C (2011) Characterization of amyloid-ß granules in the hippocampus of SAMP8 mice. J Alzheimers Dis 25, 535-546.
12. Zhang Y, He JS, Wang X, Wang J, Bao FX, Pang SY, Yin F, Hu HG, Peng XL, Sun WM, Zheng YP, Hou LL, Hong T (2011) Administration of amyloid-ß42 oligomer-specific monoclonal antibody improved memory performance in SAMP8 mice. J Alzheimers Dis 23, 551-561.
13. Banks WA, Terrell B, Farr SA, Robinson SM, Nonaka N, Morley JE (2002) Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease. Peptides 23, 2223-2226. (Pubitemid 36092057)
14. Banks WA, Farr SA, Morley JE, Wolf KM, Geylis V, Steinitz M (2007) Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: An age-related selective uptake with reversal of learning impairment. Exp Neurol 206, 248-256. (Pubitemid 47094769)
15. Morley JE, Farr SA, Flood JF (2002) Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Mem 78, 125-138. (Pubitemid 34713254)
16. Banks WA, Pagliari P, Nakaoke R, Morley JE (2005) Effects of a behaviorally active antibody on the brain uptake and clearance of amyloid beta proteins. Peptides 26, 287-294. (Pubitemid 40051424)
17. Farr SA, Banks WA, Uezu K, Sano A, Gaskin FS, Morley JE (2003) Antibody to beta-amyloid protein increases acetylcholine in the hippocampus of 12 month SAMP8 male mice. Life Sci 73, 555-562. (Pubitemid 36589035)
18. Ali AK, Banks WA, Kumar VB, Shah GN, Lynch JL, Farr SA, Fleegal-DeMotta MA, Morley JE (2009) Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: Effects of anti-amyloid antibody and antisense treatments. J Gerontol A Biol Sci Med Sci 64, 1025-1030.
19. Banks WA, Kumar VB, Farr SA, Nakaoke R, Robinson SM, Morley JE (2011) Impairments in brain-to-blood transport of amyloid-ß and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-ß protein precursor. J Alzheimers Dis 23, 599-605.
20. Poon HF, Farr SA, Banks WA, Pierce WM, Klein JB, Morley JE, Butterfield DA (2005) Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein. Brain Res Mol Brain Res 138, 8-16. (Pubitemid 41032925)
21. Poon HF, Joshi G, Sultana R, Farr SA, Banks WA, Morley JE, Calabrese V, Butterfield DA (2004) Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res 1018, 86-96. (Pubitemid 38942865)
22. Schechter I, Ziv E (2008) Kinetic properties of cathepsin D and BACE 1 indicate the need to search for additional beta-secretase candidate (s). Biol Chem 389, 313-320. (Pubitemid 351329023)
23. Hook V, Kindy M, Hook G (2007) Cysteine protease inhibitors effectively reduce in vivo levels of brainß-amyloid related to Alzheimer's disease. Biol Chem 388, 247-252. (Pubitemid 46184154)
24. Ewers M, Cheng X, Zhong Z, Nural HF, Walsh C, Meindl T, Teipel SJ, Buerger K, He P, Shen Y, Hampel H (2011) Increased CSF-BACE1 Activity Associated with Decreased Hippocampus Volume in Alzheimer's Disease. J Alzheimers Dis 25, 373-381.
25. Sandoval KE, Farr SA, Banks WA, Niehoff ML, Morley JE, Crider AM, Witt KA (2011) Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice. Eur J Pharmacol 654, 53-59.
26. Yang H, Jin G, Ren D, Luo S, Zhou T (2011) Mechanism of isoflavone aglycone's effect on cognitive performance of senescence-accelerated mice. Brain Cogn 76, 206-210.
27. Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC (2004) Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 164, 719-725. (Pubitemid 38364685)
28. Zohar O, Pick CG, Cavallaro S, Chapman J, Katzav A, Milman A, Alkon DL (2005) Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice. Neurobiol Aging 26, 1167-1175. (Pubitemid 40726009)
29. Apelt J, Bigl M, Wunderlich P, Schliebs R (2004) Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. Int J Dev Neurosci 22, 475-484. (Pubitemid 39311436)
30. He J, Luo H, Yan B, Yu Y, Wang H, Wei Z, Zhang Y, Xu H, Tempier A, Li X, Li XM (2009) Beneficial effects of queti-apine in a transgenic mouse model of Alzheimer's disease. Neurobiol Aging30, 1205-1216.
31. McAllister C, Long J, Bowers A, Walker A, Cao P, Honda S, Harada N, Staufenbiel M, Shen Y, Li R (2010) Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment. J Neurosci 30, 7326-7334.
32. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216, 92-103.
33. Kuehnle K, Ledesma MD, Kalvodova L, Smith AE, Crameri A, Skaanes-Brunner F, Thelen KM, Kulic L, Lütjohann D, Heppner FL, Nitsch RM, Mohajeri MH (2009) Age-dependent increase in desmosterol restores DRM formation and membrane-related functions in cholesterol-free DHCR24-/- mice. Neurochem Res 34, 1167-1182.
34. Fukui H, Diaz F, Garcia S, Moraes CT (2007) Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 104, 14163-14168. (Pubitemid 350003352)
35. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC (2002) ß-Secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59, 1381-1389. (Pubitemid 35014802)
36. Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, Beach T, Sue L, Sabbagh M, Cai H, Wong P, Price D, Shen Y (2004) Amyloid ß peptide load is correlated with increased ß-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci USA 101, 3632-3637. (Pubitemid 38338246)
37. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, Beach T, Sue L, Wong P, Price D, Li R, Shen Y (2003) Elevated ß-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9, 3-4. (Pubitemid 36098241)
38. Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, Logan S, Maus E, Citron M, Berry R, Binder L, Vassar R (2007) ß-Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: Implications for Alzheimer's disease pathogenesis. J Neurosci 27, 3639-3649. (Pubitemid 46557686)
39. Ahmed RR, Holler CJ, Webb RL, Li F, Beckett TL, Murphy M (2010) BACE1 and BACE2 enzymatic activities in Alzheimer's disease. J Neurochem 112, 1045-1053.
40. Chen CH, Zhou W, Liu S, Deng Y, Cai F, Tone M, Tone Y, Tong Y, Song W (2011) Increased NF-/cB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int J Neuropsychopharmacol 18, 1-14.
41. Miners JS, Morris S, Love S, Kehoe PG (2011) Accumulation of insoluble amyloid-ß in Down's syndrome is associated with increased BACE-1 and neprilysin activities. J Alzheimers Dis 23, 101-108.
42. Dreyer RN, Bausch KM, Fracasso P, Hammond LJ, Wunderlich D, Wirak DO, Davis G, Brini CM, Buckholz TM, Konig G, Kamarck ME, Tamburini PP (1994) Processing of the pre-ß-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation. Eur J Biochem 224, 265-271.
43. Ladror US, Snyder SW, Wang GT, Holzman TF, Krafft GA (1994) Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-ß by cathepsin D. J Biol Chem 269, 18422-18428. (Pubitemid 24224073)
44. Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursz-tajn S, Lippa C, Nixon RA (1995) Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14, 671-680.
45. Higaki J, Catalano R, Guzzetta AW, Quon D, Navé JF, Tarnus C, D'Orchymont H, Cordell B (1996) Processing of beta-amyloid precursor protein by cathepsin D. J Biol Chem 271, 31885-31893. (Pubitemid 26422210)
46. Chevallier N, Vizzavona J, Marambaud P, Baur CP, Spillantini M, Fulcrand P, Martinez J, Goedert M, Vincent JP, Checler F (1997) Cathepsin D displays in vitro beta-secretase-like specificity. Brain Res 750, 11-19. (Pubitemid 27116243)
47. Mackay EA, Ehrhard A, Moniatte M, Guenet C, Tardif C, Tarnus C, Sorokine O, Heintzelmann B, Nay C, Remy JM, Higaki J, Van Dorsselaer A, Wagner J, Danzin C, Mamont P (1997) A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease. Eur J Biochem 244, 414-425. (Pubitemid 27110743)
48. Schechter I, Ziv E (2011) Cathepsins S, B and L with aminopeptidases display ß-secretase activity associated with the pathogenesis of Alzheimer's disease. Biol Chem 392, 555-569.
49. Hook VY, Reisine TD (2003) Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: Role of BACE 1 in the constitutive secretory pathway. J Neurosci Res 74, 393-405. (Pubitemid 37362816)
50. Hook V, Toneff T, Bogyo M, Greenbaum D, Medzihradszky KF, Neveu J, Lane W, Hook G, Reisine T (2005) Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: Evidence for cathepsin B as a candidate b-secretase of Alzheimer's disease. Biol Chem 386, 931-940. (Pubitemid 41448149)
51. Hook VY, Kindy M, Hook G (2008) Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem 283, 7745-7753.
52. Hook G, Hook V, Kindy M (2011) The cysteine protease inhibitor, E64d, reduces brain amyloid-ß and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, ß-secretase activity. J Alzheimers Dis 26, 387-408.
53. Hook VY, Kindy M, Reinheckel T, Peters C, Hook G (2009) Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun 386, 284-288.
54. Holsinger D, McLean CA, Beyreuther K, Masters CL, Evin G (2002) Increased expression of amyloid precursor ß-secretase in Alzheimer's disease. Ann Neurol 51, 783-786. (Pubitemid 34568861)
55. Sjölander A, Zetterberg H, Andreasson U, Minthon L, Blennow K (2010) BACE1 gene variants do not influence BACE1 activity, levels of APP or Aß isoforms in CSF in Alzheimer's disease. Mol Neurodegener 5, 37.
56. Callahan LM, Chow N, Cheetham JE, Cox C, Coleman PD (1998) Analysis of message expression in single neurons of Alzheimer's disease brain. Neurobiol Aging 19, S99-S105. (Pubitemid 28178947)
57. Straface E, Matarrese P, Gambardella L, Vona R, Sgadari A, Silveri MC, Malorni W (2005) Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: A pilot study. FEBS Lett 579, 2759-2766. (Pubitemid 40725242)
58. Urbanelli L, Emiliani C, Massini C, Persichetti E, Orlacchio A, Pelicci G, Sorbi S, Hasilik A, Bernardi G, Orlacchio A (2008) Cathepsin D expression is decreased in Alzheimer's disease fibroblasts. Neurobiol Aging 29, 12-22. (Pubitemid 350102710)
59. Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, Zhou Y, Pan C, Yi E, Eng J, Wang Q, Aebersold RH, Montine TJ (2005) Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.J Alzheimers Dis 7, 125-133. (Pubitemid 40592186)
60. Nakanishi H, Tominaga K, Amano T, Hirotsu I, Inoue T, Yamamoto K (1994) Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues. Exp Neurol 126, 119-128. (Pubitemid 24131109)
61. Cho YM, Bae SH, Choi BK, Cho SY, Song CW, Yoo JK, Paik YK (2003) Differential expression of the liver proteome in senescence accelerated mice. Proteomics 3, 1883-1894. (Pubitemid 37305882)
62. Amano T, Nakanishi H, Oka M, Yamamoto K (1995) Increased expression of cathepsins E and D in reactive microglial cells associated with spongiform degeneration in the brain stem of senescence-accelerated mouse. Exp Neurol 136, 171-182.